Shalby Hospital Mohali Pioneers Non-Surgical Rezum Therapy for Prostate Treatment in North India

Chandigarh, August 27, 2024: Shalby Hospital Mohali has introduced North India’s first Rezum Therapy, a ground breaking, non-surgical treatment for an enlarged prostate, providing new hope for patients suffering from Benign Prostatic Hyperplasia (BPH). This innovative procedure, now available in India, was announced by Dr. Priyadarshi Ranjan, a renowned urologist and the Director of Urology Services at Shalby Hospital.

Dr. Ranjan, who is also the founder of the Prostate Excellence Center in Chandigarh, described Rezum Therapy as a quick, outpatient procedure that uses water vapor to treat prostate enlargement, offering a modern alternative to the conventional Transurethral Resection of the Prostate (TURP). TURP, a standard surgical method for prostate treatment, often requires a hospital stay of two to three days and results in post-treatment complications such as severe pain and a loss of sexual function.

“With Rezum Therapy, we are introducing a revolutionary shift in the treatment of prostate enlargement,” said Dr. Priyadarshi Ranjan during a press conference. “This therapy is designed to offer patients a minimally invasive solution that dramatically reduces both the physical and emotional strain traditionally associated with prostate treatment. Unlike the conventional TURP procedure, which typically involves significant recovery time, multiple days of hospitalization, and considerable postoperative discomfort, Rezum Therapy allows us to provide effective treatment in a fraction of the time. It is a 10-minute outpatient procedure performed under local anesthesia, and patients are usually discharged within just two to four hours. The therapy involves using steam injections to dissolve the excess prostate tissue, which is then naturally absorbed by the body over a period of a few weeks.”

Dr. Ranjan elaborated on the patient benefits of Rezum Therapy, emphasizing its impact on quality of life: “What truly sets this procedure apart is the preservation of sexual function, specifically ejaculation. In traditional prostate surgeries like TURP, the risk of retrograde ejaculation is significant, which can lead to a permanent loss of ejaculation. 

This can be distressing for younger patients or those who are still sexually active. With Rezum Therapy, we can treat the prostate while preserving ejaculation, making it an ideal option for men who wish to maintain their sexual health. For the first time, patients can receive treatment for an enlarged prostate without having to choose between their health and their quality of life.”

He continued, “In terms of effectiveness, Rezum Therapy boasts an impressive success rate of over 80%. The results can be life-changing for patients who have suffered from urinary retention and other symptoms related to an enlarged prostate. Most patients begin to see improvements as early as two weeks post-procedure, and the full benefits are typically experienced within three months. 

Additionally, this therapy is suitable for a wide range of patients, including those with varying sizes of prostate glands. It offers an advanced solution to address the discomfort, inconvenience, and complications associated with BPH, allowing patients to return to their normal routines far sooner than with traditional surgical methods.”

Rezum Therapy has garnered significant international attention for its efficacy and patient-centered approach, and Shalby Hospital Mohali is proud to be the first in North India to offer this cutting-edge technology. The procedure is priced at approximately Rs 2.5 lakh, comparable to TURP, but with faster recovery and reduced risk of side effects.

“With this revolutionary technology now available at Shalby Hospital Mohali, we are empowering men with a safer, less invasive option for prostate care,” Dr. Ranjan concluded. “Our goal is to improve the quality of life for patients suffering from BPH while maintaining their overall well-being, and we are thrilled to be at the forefront of this medical advancement in India.”